Pro-resolving lipid mediators: regulators of inflammation, metabolism and kidney function

E Brennan, P Kantharidis, ME Cooper… - Nature Reviews …, 2021 - nature.com
Obesity, diabetes mellitus, hypertension and cardiovascular disease are risk factors for
chronic kidney disease (CKD) and kidney failure. Chronic, low-grade inflammation is …

Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment

ME Ertunc, GS Hotamisligil - Journal of lipid research, 2016 - ASBMB
Lipids encompass a wide variety of molecules such as fatty acids, sterols, phospholipids,
and triglycerides. These molecules represent a highly efficient energy resource and can act …

Molecular and cellular mechanisms linking inflammation to insulin resistance and β-cell dysfunction

H Khodabandehloo, S Gorgani-Firuzjaee… - Translational …, 2016 - Elsevier
Obesity is a major public health problem worldwide, and it is associated with an increased
risk of developing type 2 diabetes. It is now commonly accepted that chronic inflammation …

Inflammation and the metabolic syndrome: the tissue-specific functions of NF-κB

L Catrysse, G van Loo - Trends in cell biology, 2017 - cell.com
Obesity is becoming a major health concern in Western society, and medical conditions
associated with obesity are grouped in the metabolic syndrome. Overnutrition activates …

Vitamin D switches BAF complexes to protect β cells

Z Wei, E Yoshihara, N He, N Hah, W Fan, AFM Pinto… - Cell, 2018 - cell.com
A primary cause of disease progression in type 2 diabetes (T2D) is β cell dysfunction due to
inflammatory stress and insulin resistance. However, preventing β cell exhaustion under …

NLRP3 inflammasome at the interface of inflammation, endothelial dysfunction, and type 2 diabetes

IM Gora, A Ciechanowska, P Ladyzynski - Cells, 2021 - mdpi.com
Type 2 diabetes mellitus (T2DM), accounting for 90–95% cases of diabetes, is characterized
by chronic inflammation. The mechanisms that control inflammation activation in T2DM are …

[HTML][HTML] Oxidative and endoplasmic reticulum stress in β-cell dysfunction in diabetes

SZ Hasnain, JB Prins… - Journal of molecular …, 2016 - jme.bioscientifica.com
The inability of pancreatic β-cells to make sufficient insulin to control blood sugar is a central
feature of the aetiology of most forms of diabetes. In this review we focus on the deleterious …

Mechanisms underlying the effect of polysaccharides in the treatment of type 2 diabetes: A review

J Wu, S Shi, H Wang, S Wang - Carbohydrate polymers, 2016 - Elsevier
Type 2 diabetes mellitus, a common metabolic and endocrine disorder worldwide, causes
severe health and economic problems. At present, pharmacotherapy involving synthetic …

Coumarins as potential antidiabetic agents

H Li, Y Yao, L Li - Journal of Pharmacy and Pharmacology, 2017 - academic.oup.com
Objectives Even with great advances in modern medicine and therapeutic agent
development, the search for effective antidiabetic drugs remains challenging. Coumarins are …

[HTML][HTML] Mitophagy protects β cells from inflammatory damage in diabetes

V Sidarala, GL Pearson, VS Parekh, B Thompson… - JCI insight, 2020 - ncbi.nlm.nih.gov
Inflammatory damage contributes to β cell failure in type 1 and 2 diabetes (T1D and T2D,
respectively). Mitochondria are damaged by inflammatory signaling in β cells, resulting in …